An arginine analog inhibits responses of both the endothelium and smooth muscle of canine in situ vein grafts

Vascular

Volumn 5, Issue 2, 1997, Pages 169-175

  Rhee, R Y ^a   Gloviczki, P ^a   Miller, V M ^a  

^a MAYO CLINIC   (United States)

Author keywords

adenosine diphosphate; calcium ionophore A23187; endothelium; L NMMA; nitric oxide; smooth muscle; UK 14,304; vein grafts

Indexed keywords

ADENOSINE DIPHOSPHATE; ARGININE DERIVATIVE; CALCIMYCIN; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DOG; ENZYME LOCALIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; SHEAR STRESS; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VEIN GRAFT;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; ARGININE; CALCIMYCIN; DOGS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FEMORAL ARTERY; FEMORAL VEIN; GRAFT OCCLUSION, VASCULAR; IONOPHORES; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; ORGAN CULTURE TECHNIQUES; QUINOXALINES; VASCULAR RESISTANCE; VEINS;

EID: 0030996884     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.1177/096721099700500206     Document Type: Article

References (37)

1. Garg U. C., Hassid A., Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. Journal of Clinical Investigation, 1989, 83, 1774–1777.
2. Miller V. M., Vanhoutte P. M., Is nitric oxide the only endothelium-derived relaxing factor in canine femoral veins? American Journal of Physiology, 1989, 257, H1910-H1916.
3. Kolpakov V., Gordon D., Kulik T. J., Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. Circulation Research, 1995, 76, 305–309.
4. Ziche M., Morbidelli L., Masini E., Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. Journal of Clinical Investigation, 1994, 94, 2036–2044.
5. Nishida K., Harrison D. G., Navas J. P., Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. Journal of Clinical Investigation, 1992, 90, 2092–2096.
6. Miller V. M., Burnett J. C., Modulation of nitric oxide and endothelin by chronic increases in blood flow in canine femoral arteries. American Journal of Physiology, 1992, 263, H103-H108.
7. Miller V. M., Aarhus L. L., Vanhoutte P. M., Modulation of endothelium-dependent responses by chronic alterations of blood flow. American Journal of Physiology, 1986, 251, H520-H527.
8. Miller V. M., Barber D. A., Modulation of endothelium-derived nitric oxide in canine femoral veins. American Journal of Physiology 1996, 271, H668-H673.
9. Von Der Leyen H.E., Gibbons G.H., Morishita R., Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proceedings of the National Academy of Science USA, 1995, 92, 1137–1141.
10. Davies M. G., Kim J. H., Dalen H., Makhoul R. G., Svendsen E., Hagen P., Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor l-arginine. Surgery, 1994, 116, 557–568.
11. Davies M. G., Berkowitz D. E., Hagen P. O., Constitutive nitric oxide synthase is expressed and nitric oxide-mediated relaxation is preserved in retrieved human aortocoronary vein grafts. Journal of Surgical Research, 1995, 58(6), 732–738.
12. Davies M. G., Ramkumar V., Gettys T. W., Hagen P. O., The expression and function of G-proteins in experimental intimal hyperplasia. Journal of Clinical Investigation, 1994, 94(4), 1680–1689.
13. Cross K. S., Davies M. G., El-Sanadiki, M. N., Murray, J. J., Mikat, E. M. and Hagen, P. O., Long-term human vein graft contractility and morphology: A functional and histopathological study of retrieved coronary vein grafts. British Journal of Surgery, 1994, 81(5), 699–705.
14. Miller V. M., Reigel M. M., Hollier L. H., Vanhoutte P. M., Endothelium-dependent responses in autogenous femoral veins grafted into the arterial circulation of the dog. Journal of Clinical Investigation, 1987, 80, 1350–1357.
15. Miller V. M., Bower T. C., McCullough J. L., Gloviczki P., Vanhoutte P. M., Endothelium-dependent responses in nonreversed (in situ) vein grafts. Journal of Vascular Medical Biology, 1990, 2, 155–162.
16. Komori K., Gloviczki P., Bourchier R. G., Miller V. M., Vanhoutte P. M., Endothelium-dependent vasorelaxations in response to aggregating platelets are impaired in reversed vein grafts. Journal of Vascular Surgery, 1990, 12, 139–147.
17. Miller V. M., Selective production of endothelium-derived nitric oxide in canine femoral veins. American Journal of Physiology, 1991, 261, H677-H682.
18. Segers M. J., Moll F. L. V. D. Molengraft F. J., Klopper P. J., Intimal hyperplasia in reversed and in situ vein grafts: an intra-individual canine study. Journal of Investigative Surgery, 1994, 7(2), 159–165.
19. Harris P. L., Veith F. J., Shanik G. D., Nott D., Wengerter K. R., Moore D. J., Prospective randomized comparison of in situ and reversed infrapopliteal vein grafts. British Journal of Surgery, 1993, 80(2), 173–176.
20. Cambria R. A., Lowell R. C., Gloviczki P., Miller V. M., Chronic changes in blood flow alter endothelium-dependent responses in autogenous vein grafts in dogs. Journal of Vascular Surgery, 1994, 20, 765–773.
21. Vanhoutte P. M., Leusen I., The reactivity of isolated venous preparations to electrical stimulation. Pflugers Archiv, 1969, 306, 341–353.
22. Palmer R. M. J., Rees D. D., Ashton D. S., Moncada S., L-Arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochemical and Biophysical Research Communications, 1988, 153, 1251–1256.
23. Rees D. D., Palmer R. M. J., Hodson H. F., Moncada S., A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. British Journal of Pharmacology, 1989, 96, 418–424.
24. Palmer R. M. J., Ferrige A. G., Moncada S., The release of nitric oxide by vascular endothelial cells accounts for the activity of EDRF. Nature, 1987, 327, 524–526.
25. Miller V. M., Flavahan N. A., Vanhoutte P. M., Pertussis toxin reduces endothelium-dependent and independent responses to alpha2-adrenergic stimulation in systemic canine arteries and veins. Journal of Pharmacology and Experimental Therapeutics, 1991, 257, 290–293.
26. Mugge A., Elwell J. H., Peterson T. E., Harrison D. G., Release of intact endothelium-derived relaxing factor depends on endothelial superoxide dismutase activity. American Journal of Physiology, 1991, 260, C219-C225.
27. Koppenol W. H., Moreno J. J., Pryor W. A., Ischiropoulos H., Beckman J. S., Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chemistry and Research in Toxicology, 1992, 5, 834–842.
28. Beckmann J. S., Ye Y. A., Anderson P. G., Chen J., Accavitti M. A., Tarpey M. M., White C. R., Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biological Chemistry Hoppe-Seyler, 1994, 375, 81–88.
29. Lewis D. A., Miller V. M., Role of lipoxygenase and cytochrome-P450 in the production of endothelium-derived relaxing factors in canine femoral veins. Journal of Cardiovascular Pharmacology, 1992, 20, 401–407.
30. Schini V. B., Junquero D. C., Scott-Burden, T. and Vanhoutte, P. M., Interleukin-1b induces the production of an l-arginine-derived relaxing factor from cultured smooth muscle cells from rat aorta. Biochemical and Biophysical Research Communications, 1991, 176, 114–121.
31. Junquero D. C., Scott-Burden, T., Schini, V. B. and Vanhoutte, P. M., Inhibition of cytokine-induced nitric oxide production by transforming growth factor-b1 in human smooth muscle cells. Journal of Physiology, 1992, 454, 451–465.
32. Scott-Burden T., Schini V. B., Elizondo E., Junquero D. C., Vanhoutte P. M., Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells. Circulation Research, 1992, 71, 1088–1100.
33. Durante W., Schini V. B., Catovsky S., Kroll M. H., Vanhoutte P. M., Schafer A. I., Plasmin potentiates induction of nitric oxide synthesis by interleukin-1b in vascular smooth muscle cells. American Journal of Physiology, 1993, 264, H617-H624.
34. Venema R. C., Nishida K., Alexander R. W., Harrison D. G., Murphy T. J., Organization of the bovine gene encoding the endothelial nitric oxide synthase. Biochimica et Biophysica Acta, 1994, 1218, 413–420.
35. Sessa W. C., Pritchard K., Seyedi N., Wang J., Hintze T. H., Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circulation Research, 1994, 74, 349–353.
36. Durante W., Schini V. B., Scott-Burden, T., Junquero, D. C., Kroll, M. H., Vanhoutte, P. M. and Schafer, A. I., Platelet inhibition by an l-arginine-derived substance released by IL-1b-treated vascular smooth muscle cells. American Journal of Physiology, 1991, 261, H2024-H2030.
37. Fogle M. A., Whittemore A. D., Couch N. P., Mannick J. A., A comparison of in situ and reversed saphenous vein grafts for infrainguinal reconstruction. Journal of Vascular Surgery, 1987, 5, 46–52.